Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CBT Stock Forecast 2026-2027
$89.21
Current Price
$4.61B
Market Cap
Buy 2
Hold 3
Sell 1
Wall St Analyst Ratings
Distance to CBT Price Targets
+9.9%
To High Target of $98.00
-4.2%
To Median Target of $85.50
-21.5%
To Low Target of $70.00
CBT Price Momentum
+5.7%
1 Week Change
+10.1%
1 Month Change
+19.8%
1 Year Change
+34.6%
Year-to-Date Change
-0.3%
From 52W High of $89.46
+52.9%
From 52W Low of $58.33
📊 TOP ANALYST CALLS
Did CBT Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cabot is one of their latest high-conviction picks.
Latest CBT Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, CBT has a neutral consensus with a median price target of $85.50 (ranging from $70.00 to $98.00). The overall analyst rating is Buy (7.0/10). Currently trading at $89.21, the median forecast implies a -4.2% downside. This outlook is supported by 2 Buy, 3 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Peter Osterland at Truist Securities, projecting a 9.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CBT Analyst Ratings
2
Buy
3
Hold
1
Sell
CBT Price Target Range
Low
$70.00
Average
$85.50
High
$98.00
Current: $89.21
Latest CBT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CBT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 8, 2026 | Truist Securities | Peter Osterland | Buy | Initiates | $98.00 |
| May 13, 2026 | JP Morgan | Underweight | Maintains | $N/A | |
| May 8, 2026 | UBS | Neutral | Maintains | $N/A | |
| May 6, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| Feb 5, 2026 | UBS | Neutral | Maintains | $N/A | |
| Feb 5, 2026 | Mizuho | Neutral | Downgrade | $N/A | |
| Jan 12, 2026 | UBS | Neutral | Maintains | $N/A | |
| Dec 18, 2025 | Mizuho | Outperform | Maintains | $N/A | |
| Nov 28, 2025 | JP Morgan | Underweight | Maintains | $N/A | |
| Nov 17, 2025 | Mizuho | Outperform | Maintains | $N/A | |
| Nov 5, 2025 | UBS | Neutral | Maintains | $N/A | |
| Oct 3, 2025 | Mizuho | Outperform | Maintains | $N/A | |
| Aug 5, 2025 | UBS | Neutral | Maintains | $N/A | |
| Apr 7, 2025 | UBS | Neutral | Maintains | $N/A | |
| Feb 21, 2025 | JP Morgan | Underweight | Maintains | $N/A | |
| Jan 7, 2025 | Mizuho | Outperform | Maintains | $N/A | |
| Nov 11, 2024 | JP Morgan | Underweight | Downgrade | $N/A | |
| Nov 5, 2024 | Mizuho | Outperform | Maintains | $N/A | |
| Aug 7, 2024 | JP Morgan | Neutral | Maintains | $N/A | |
| Aug 6, 2024 | UBS | Neutral | Maintains | $N/A |
Cabot Corporation (CBT) Competitors
The following stocks are similar to Cabot based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cabot Corporation (CBT) Financial Data
Cabot Corporation has a market capitalization of $4.61B with a P/E ratio of 16.7x. The company generates $3.58B in trailing twelve-month revenue with a 8.0% profit margin.
Revenue growth is -3.4% quarter-over-quarter, while maintaining an operating margin of +15.3% and return on equity of +20.0%.
Valuation Metrics
Market Cap
$4.61B
Enterprise Value
$5.70B
P/E Ratio
16.7x
PEG Ratio
-0.6x
Price/Sales
1.3x
Growth & Margins
Revenue Growth (YoY)
-3.4%
Gross Margin
+23.2%
Operating Margin
+15.3%
Net Margin
+8.0%
EPS Growth
-27.7%
Financial Health
Cash/Price Ratio
+5.5%
Current Ratio
1.4x
Debt/Equity
77.7x
ROE
+20.0%
ROA
+9.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cabot Corporation (CBT) Business Model
About Cabot Corporation
What They Do
Produces specialty chemicals and performance materials.
Business Model
Cabot Corporation generates revenue by manufacturing and supplying specialty chemicals and performance materials such as carbon black, fumed silica, and activated carbon. These materials are critical components for a variety of industries, including automotive, construction, and electronics, enhancing the performance and durability of products like tires and batteries.
Additional Information
Founded in 1882, Cabot Corporation has a strong commitment to innovation and sustainability, focusing on improving the environmental impact of its operations. The company's global presence and expertise in material science position it as a key player in supporting infrastructure development and advancing technology in both industrial and consumer markets.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
4,151
CEO
Mr. Sean D. Keohane
Country
United States
IPO Year
1980
Website
www.cabotcorp.comCabot Corporation (CBT) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Why Is Albemarle (ALB) Down 16.5% Since Last Earnings Report?
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jun 05, 2026
By Zacks Equity Research
Realtime BLOG
Why Is Cabot (CBT) Up 3.5% Since Last Earnings Report?
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jun 04, 2026
By Zacks Equity Research
Realtime BLOG
Latest News
Quick Summary
Cabot (CBT) reported earnings 30 days ago; investors may want to monitor upcoming developments and performance indicators for future stock movements.
Why It Matters
Earnings reports can impact stock prices and investor sentiment. Upcoming developments or guidance from Cabot may influence future stock performance and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Cabot Corporation (CBT) held its Q2 2026 earnings call, discussing financial performance and strategic initiatives. Further details on revenue and projections were provided.
Why It Matters
Cabot Corporation's Q2 2026 earnings call provides insights into financial performance, growth strategies, and market trends, influencing stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Cabot Corporation (NYSE: CBT) reported Q2 FY 2026 diluted EPS of $1.27 and adjusted EPS of $1.61. Net sales were $904 million. A 5% dividend increase was announced. EBIT for Reinforcement Materials and Performance Chemicals was $93 million and $59 million, respectively.
Why It Matters
Cabot Corporation's strong earnings and dividend increase signal robust financial health, while asset optimization may enhance future profitability amidst evolving market demands.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Cabot (CBT) Surpasses Q2 Earnings Estimates
1 month ago
Quick Summary
Cabot (CBT) reported quarterly earnings of $1.61 per share, exceeding the Zacks Consensus Estimate of $1.47, but down from $1.90 per share a year prior.
Why It Matters
Cabot's earnings beat expectations, signaling strong performance despite a year-over-year decline. This may boost investor confidence and influence stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
CBT exceeded fiscal Q2 earnings expectations, driven by strong demand for battery materials and a favorable product mix, despite facing weaker pricing and lower revenues.
Why It Matters
CBT's Q2 earnings beat suggests strong demand for battery materials, indicating potential growth in emerging markets despite pricing pressures, which may attract investor interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Cabot Corporation Wins Responsible Care® Awards for Exceptional Safety and Sustainability Performance
1 month ago
Quick Summary
Cabot Corporation (NYSE: CBT) received two 2026 Responsible Care® Awards for Waste & Water Stewardship and Facility Safety, highlighting its commitment to environmental and employee safety standards.
Why It Matters
Cabot Corporation's Responsible Care® Awards enhance its reputation, potentially attracting socially conscious investors and improving long-term financial performance through sustainable practices.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About CBT Stock
What is Cabot Corporation's (CBT) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Cabot Corporation (CBT) has a median price target of $85.50. The highest price target is $98.00 and the lowest is $70.00.
Is CBT stock a good investment in 2026?
According to current analyst ratings, CBT has 2 Buy ratings, 3 Hold ratings, and 1 Sell ratings. The stock is currently trading at $89.21. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CBT stock?
Wall Street analysts predict CBT stock could reach $85.50 in the next 12 months. This represents a -4.2% decrease from the current price of $89.21. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cabot Corporation's business model?
Cabot Corporation generates revenue by manufacturing and supplying specialty chemicals and performance materials such as carbon black, fumed silica, and activated carbon. These materials are critical components for a variety of industries, including automotive, construction, and electronics, enhancing the performance and durability of products like tires and batteries.
What is the highest forecasted price for CBT Cabot Corporation?
The highest price target for CBT is $98.00 from Peter Osterland at Truist Securities, which represents a 9.9% increase from the current price of $89.21.
What is the lowest forecasted price for CBT Cabot Corporation?
The lowest price target for CBT is $70.00 from at , which represents a -21.5% decrease from the current price of $89.21.
What is the overall CBT consensus from analysts for Cabot Corporation?
The overall analyst consensus for CBT is neutral. Out of 2 Wall Street analysts, 2 rate it as Buy, 3 as Hold, and 1 as Sell, with a median price target of $85.50.
How accurate are CBT stock price projections?
Stock price projections, including those for Cabot Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 16, 2026 2:50 AM UTC